Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

Ectoin helps prevent cortisone-induced skin problems and supports skin health.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Tridax procumbens is a versatile herb with many health benefits.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tideglusib with hydrogel improves wound healing in rats.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Tofacitinib may help regrow hair in alopecia areata patients.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

TQC shows promise for better hair regrowth in treating hair loss.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Enhancing Tregs can protect against alopecia areata.

Specific brain and bone imaging findings can help diagnose Trichothiodystrophy.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Neurotrophin-4 increases calcium current in specific mouse neurons through the PI3K pathway.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

Tideglusib with a bacterial cellulose hydrogel improves wound healing in rats.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

The research developed new fortilin protein constructs for potential heart disease treatments.